Upgrade to SI Premium - Free Trial

AnaptysBio (ANAB) PT Lowered to $45 at Leerink Partners

November 6, 2024 5:58 AM
Leerink Partners analyst David Risinger lowered the price target on AnaptysBio (NASDAQ: ANAB) to $45.00 (from $47.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles